TCG Crossover Management, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001839948 · Show all filings

Period: Q4 2025 (← Previous) (Next →)

Filing Date: Feb 17, 2026

Total Value: $3.022B (100.0% shares, 0.0% debt)

Holdings (43)

ABVX ABIVAX SA AMERICAN DEPOSITARY SHARES 31.7%
Value $959M Shares 7,111,596 Est. Cost $23.46 Unrealized
COGT COGENT BIOSCIENCES INC 6.9%
Value $208M Shares 5,868,162 Est. Cost $9.05 Unrealized +210.6%
CGON CG ONCOLOGY INC 5.0%
Value $152M Shares 3,670,206 Est. Cost $40.67 Unrealized +1.7%
TNGX TANGO THERAPEUTICS INC 3.7%
Value $113M Shares 12,762,094 Est. Cost $5.96 Unrealized +44.6%
CNTA CENTESSA PHARMACEUTICALS PLC 3.5%
Value $107M Shares 4,286,480 Est. Cost $12.97 Unrealized
DYN DYNE THERAPEUTICS INC 3.0%
Value $90.27M Shares 4,615,144 Est. Cost $14.30 Unrealized +32.4%
RAPT RAPT THERAPEUTICS INC 2.9%
Value $87.47M Shares 2,582,408 Est. Cost $16.21 Unrealized +91.6%
TYRA TYRA BIOSCIENCES INC 2.5%
Value $76.19M Shares 2,898,103 Est. Cost $12.78 Unrealized +43.7%
AMLX AMYLYX PHARMACEUTICALS INC 2.5%
Value $75.43M Shares 6,243,812 Est. Cost $2.86 Unrealized +374.1%
SVRA SAVARA INC 2.5%
Value $74.54M Shares 12,362,205 Est. Cost $3.73 Unrealized +31.2%
GLUE MONTE ROSA THERAPEUTICS INC 2.4%
Value $72.48M Shares 4,622,151 Est. Cost $13.48 Unrealized 0.0%
OCUL OCULAR THERAPEUTIX INC 2.3%
Value $69.69M Shares 5,740,231 Est. Cost $7.73 Unrealized +57.1%
DNTH DIANTHUS THERAPEUTICS INC 2.3%
Value $69.09M Shares 1,676,624 Est. Cost $25.70 Unrealized +50.9%
EYPT EYEPOINT PHARMACEUTICALS INC 2.2%
Value $65.27M Shares 3,572,335 Est. Cost $10.51 Unrealized +34.8%
GPCR STRUCTURE THERAPEUTICS INC 2.1%
Value $64.05M Shares 920,857 Est. Cost $43.45 Unrealized
SYRE SPYRE THERAPEUTICS INC 2.1%
Value $62.26M Shares 1,900,582 Est. Cost $20.44 Unrealized +27.8%
FULC FULCRUM THERAPEUTICS INC 2.0%
Value $59.38M Shares 5,250,000 Est. Cost $7.42 Unrealized +37.2%
LQDA LIQUIDIA TECHNOLOGIES INC 2.0%
Value $58.98M Shares 1,710,084 Est. Cost $21.69 Unrealized +31.2%
BHVN BIOHAVEN LTD 1.7%
Value $52.29M Shares 4,631,317 Est. Cost $12.39 Unrealized 0.0%
IMVT IMMUNOVANT INC 1.4%
Value $42.22M Shares 1,660,933 Est. Cost $22.30 Unrealized 0.0%
KOD KODIAK SCIENCES INC 1.3%
Value $40.42M Shares 1,445,538 Est. Cost $7.55 Unrealized +171.3%
ADCT ADC THERAPEUTICS SA 1.3%
Value $40.21M Shares 11,390,175 Est. Cost $3.95 Unrealized +2.8%
LBRX LB PHARMACEUTICALS INC 1.3%
Value $38.84M Shares 1,745,015 Est. Cost $15.87 Unrealized +10.1%
XNCR XENCOR INC 1.2%
Value $37.54M Shares 2,452,138 Est. Cost $18.82 Unrealized -20.6%
RVMD REVOLUTION MEDICINES INC 1.2%
Value $34.77M Shares 436,473 Est. Cost $39.15 Unrealized +67.5%
AGIO AGIOS PHARMACEUTICALS INC 1.1%
Value $32.17M Shares 1,181,841 Est. Cost $34.05 Unrealized +3.0%
ARVN ARVINAS HOLDING CO LLC 1.0%
Value $31.62M Shares 2,666,216 Est. Cost $8.90 Unrealized +22.7%
RLAY RELAY THERAPEUTICS INC 0.9%
Value $27.24M Shares 3,220,186 Est. Cost $5.27 Unrealized +35.5%
JANX JANUX THERAPEUTICS INC 0.8%
Value $24.7M Shares 1,789,617 Est. Cost $23.52 Unrealized 0.0%
TRDA ENTRADA THERAPEUTICS INC 0.7%
Value $21.47M Shares 2,088,392 Est. Cost $12.20 Unrealized
MBX MBX BIOSCIENCES INC 0.7%
Value $20.5M Shares 650,000 Est. Cost $22.87 Unrealized +6.1%
UPB UPSTREAM BIO INC 0.7%
Value $20.2M Shares 743,886 Est. Cost $22.33 Unrealized +11.5%
SLN SILENCE THERAPEUTICS PLC 0.6%
Value $18.44M Shares 3,033,560 Est. Cost $14.21 Unrealized
URGN UROGEN PHARMA LTD 0.6%
Value $16.8M Shares 717,347 Est. Cost $17.96 Unrealized +20.8%
ALEC ALECTOR INC 0.5%
Value $15.6M Shares 10,000,000 Est. Cost $1.77 Unrealized 0.0%
MNPR MONOPAR THERAPEUTICS INC 0.3%
Value $9.267M Shares 141,915 Est. Cost $44.70 Unrealized +82.8%
AVTX AVALO THERAPEUTICS INC 0.3%
Value $8.771M Shares 483,000 Est. Cost $10.31 Unrealized +63.7%
MAZE MAZE THERAPEUTICS INC 0.2%
Value $7.201M Shares 173,816 Est. Cost $34.37 Unrealized 0.0%
MIRM MIRUM PHARMACEUTICALS INC 0.2%
Value $4.901M Shares 62,049 Est. Cost $71.78 Unrealized 0.0%
LONA Athira Pharma, Inc. 0.1%
Value $3.349M Shares 464,398 Est. Cost $4.58 Unrealized 0.0%
KRRO KORRO BIO INC 0.1%
Value $3.335M Shares 416,301 Est. Cost $22.19 Unrealized +5.3%
VTYX VENTYX BIOSCIENCES INC 0.1%
Value $2.855M Shares 316,195 Est. Cost $29.94 Unrealized -75.0%
VTGN VISTAGEN THERAPEUTICS INC 0.1%
Value $1.772M Shares 2,676,580 Est. Cost $3.41 Unrealized +5.9%